New age health startups are all the rage right now and rightly so since they are introducing new ways to better our health and lives. By leveraging some of the cutting edge technologies available, many medtech startups have already made a name for themselves. The UK-based healthtech startup Medopad is one such company that has come a long way since it was established in 2011.
Funding details
Medopad has announced of securing €22.5M in Series B round of investment, which was led by Leaps By Bayers. With the new investment, Medopad’s total amount raised till now stands over €45 million and with the freshly acquired funds, the company aims to support new clinical studies, including digital biomarker discovery and creation of digital therapeutics (DTx). It will also focus on technology development, geographic expansion and